Animal models of spontaneous autoimmune disease: type 1 diabetes in the nonobese diabetic mouse
- PMID: 17876100
- DOI: 10.1007/978-1-59745-395-0_17
Animal models of spontaneous autoimmune disease: type 1 diabetes in the nonobese diabetic mouse
Abstract
The nonobese diabetic (NOD) mouse represents probably the best spontaneous model for a human autoimmune disease. It has provided not only essential information on type 1 diabetes (T1D) pathogenesis, but also valuable insights into mechanisms of immunoregulation and tolerance. Importantly, it allows testing of immunointervention strategies potentially applicable to man. The fact that T1D incidence in the NOD mouse is sensitive to environmental conditions, and responds, sometimes dramatically, to immunomanipulation, does not represent a limit of the model, but is likely to render it even more similar to its human counterpart. In both cases, macrophages, dendritic cells, CD4+, CD8+, and B cells are present in the diseased islets. T1D is a polygenic disease, but, both in human and in NOD mouse T1D, the primary susceptibility gene is located within the MHC. On the other hand, T1D incidence is significantly higher in NOD females, although insulitis is similar in both sexes, whereas in humans, T1D occurs with about equal frequency in males and females. In addition, NOD mice have a more widespread autoimmune disorder, which is not the case in the majority of human T1D cases. Despite these differences, the NOD mouse remains the most representative model of human T1D, with similarities also in the putative target autoantigens, including glutamic acid decarboxylase IA-2, and insulin.
Similar articles
-
Coxsackievirus B3 infection and type 1 diabetes development in NOD mice: insulitis determines susceptibility of pancreatic islets to virus infection.Virology. 2004 Nov 24;329(2):381-94. doi: 10.1016/j.virol.2004.06.049. Virology. 2004. PMID: 15518817
-
Natural history of humoral immunity to glutamic acid decarboxylase in non-obese diabetic (NOD) mice.J Autoimmun. 1994 Oct;7(5):643-53. doi: 10.1006/jaut.1994.1049. J Autoimmun. 1994. PMID: 7840856
-
Autoimmunity triggers in the NOD mouse: a role for natural auto-antibody reactivities in type 1 diabetes.Ann N Y Acad Sci. 2009 Sep;1173:442-8. doi: 10.1111/j.1749-6632.2009.04661.x. Ann N Y Acad Sci. 2009. PMID: 19758184
-
Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice.Ann N Y Acad Sci. 2005 Jun;1051:72-87. doi: 10.1196/annals.1361.048. Ann N Y Acad Sci. 2005. PMID: 16126946 Review.
-
Genetic and immunological basis of autoimmune diabetes in the NOD mouse.Rev Immunogenet. 2000;2(1):140-6. Rev Immunogenet. 2000. PMID: 11324686 Review.
Cited by
-
Fatty acid synthase modulates homeostatic responses to myocardial stress.J Biol Chem. 2011 Sep 2;286(35):30949-30961. doi: 10.1074/jbc.M111.230508. Epub 2011 Jul 8. J Biol Chem. 2011. PMID: 21757749 Free PMC article.
-
Self-antigen expression in the peripheral immune system: roles in self-tolerance and type 1 diabetes pathogenesis.Curr Diab Rep. 2014;14(9):525. doi: 10.1007/s11892-014-0525-x. Curr Diab Rep. 2014. PMID: 25030265 Review.
-
Diabetes, adult neurogenesis and brain remodeling: New insights from rodent and zebrafish models.Neurogenesis (Austin). 2017 Jan 31;4(1):e1281862. doi: 10.1080/23262133.2017.1281862. eCollection 2017. Neurogenesis (Austin). 2017. PMID: 28439518 Free PMC article. Review.
-
Endogenous programmed death ligand-1 restrains the development and onset of Sjӧgren's syndrome in non-obese diabetic mice.Sci Rep. 2016 Dec 14;6:39105. doi: 10.1038/srep39105. Sci Rep. 2016. PMID: 27966604 Free PMC article.
-
Novel epitope begets a novel pathway in type 1 diabetes progression.J Clin Invest. 2008 Oct;118(10):3268-71. doi: 10.1172/JCI37125. J Clin Invest. 2008. PMID: 18802485 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials